⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NTHI News
NeOnc Technologies Holdings, Inc. Common Stock
Form 8-K
sec.gov
NTHI
NeOnc Technologies Appoints David Choi as Chief Accounting Officer
globenewswire.com
NTHI
NeOnc Technologies Appoints David Choi as Chief Accounting Officer
globenewswire.com
NTHI
Glafabra Therapeutics Receives FDA Orphan Drug Designation for GT-GLA-S03, Advancing a Redosable Cell Therapy for Fabry Disease Ready to Announce with Confidence?
newsfilecorp.com
OPFI
NTHI
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) Ready to Announce with Confidence?
newsfilecorp.com
NTHI
Form 8-K
sec.gov
NTHI
Form 8-K
sec.gov
NTHI
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET
globenewswire.com
MRK
NTHI
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET
globenewswire.com
NTHI
MRK
Form 8-K
sec.gov
NTHI